Innovis Asset Management LLC Autolus Therapeutics PLC Transaction History
Innovis Asset Management LLC
- $260 Billion
- Q3 2023
A detailed history of Innovis Asset Management LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Innovis Asset Management LLC holds 63,179 shares of AUTL stock, worth $248,293. This represents 0.06% of its overall portfolio holdings.
Number of Shares
63,179
Previous 63,179
-0.0%
Holding current value
$248,293
Previous $150 Million
2.1%
% of portfolio
0.06%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding AUTL
# of Institutions
122Shares Held
167MCall Options Held
411KPut Options Held
67.6K-
Syncona Portfolio LTD Guernsey, Channel Islands, X021.3MShares$83.9 Million90.76% of portfolio
-
Blackstone Inc New York, NY20.5MShares$80.5 Million0.54% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$60 Million3.22% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$48.5 Million0.95% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$42.3 Million0.01% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $357M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...